Clover Health Investments (CLOV) Reports Q2 results; offers guidance

Clover Health Investments (NASDAQ: CLOV) reported Q2 Revenue for the quarter at $477.62 million versus the consensus estimate of $468.3 million.

GUIDANCE:

Clover Health Investments sees FY2025 revenue of $1.8-1.875 billion, versus the consensus of $1.863 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c